Form 4 for CVS CVS Health
Accepted 2021-12-01 00:00:00 ET · period of report 2021-11-28 · accession 0001127602-21-029913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-01 | 2021-11-28 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $91.52 | -14.1K | 69.1K | -17% | -$1.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-28 | F | D | 14,121 | $91.52 | 69,114 | D | — | — |